Aakha Biologics, Inc. — Form D
Aakha Biologics, Inc. of FRISCO, TX, a company, filed a Form D exempt-offering notice with the SEC on 2024-07-17. The offering totals $5.0M, of which $750K was reported sold. Industry: Biotechnology.
Offering
- Filed: 2024-07-17
- Form: D
- Accession: 0002030720-24-000001
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $5.0M
- Amount sold: $750K
- Remaining: $4.3M
- Investors: 1
- Date of first sale: 2024-07-02
- Security types: debt
- Revenue range: Decline to Disclose
- SEC file number: 021-519031
Issuer
- Name: Aakha Biologics, Inc.
- CIK: 0002030720
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2022
- Address: 5680 FRISCO SQ. BLVD., FRISCO, TX, 75034
- Phone: (617) 276-4715
Officers, directors & promoters (5)
| Name | Role | Location |
|---|
| Errik Anderson | Director | Cambridge, MA |
| Hemanta Baruah | Director | Frisco, TX |
| George Robert Mabry III | Director | Frisco, TX |
| Christopher Pacheco | Director | Frisco, TX |
| Hemanta Baruah | Executive Officer | Frisco, TX |
More